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New Swiss guidelines on scientific integrity: a
step in the right direction, but still not enough
Roberto Andorno
Institute of Biomedical Ethics and History of Medicine, University of Zurich
On May 2021, the Swiss Academies of Arts and Sciences
(SAAS) announced the publication of new guidelines on
scientific integrity under the title “Code of conduct for sci-
entific integrity” (hereafter “the Code”) [1]. The document
was developed by a group of experts from the SAAS, the
Swiss National Science Foundation, the Rectors' Confer-
ence of the Swiss Universities (swissuniversities), and the
Swiss Innovation Agency (Innosuisse). The Code is an up-
dated and expanded version of the document titled "In-
tegrity in scientific research. Principles and procedures"
that was issued by the SAAS in 2008.
The declared aim of the new guidelines is “to promote re-
sponsible conduct of research in every area of scientific
research and education.” More specifically, it intends “to
promote a common understanding of behaviours that vio-
late scientific integrity”; to identify a “set of principles” in
this area; to foster “equal treatment” of these issues across
institutions in Switzerland; and “to provide a basis for reg-
ulations and guidelines on scientific integrity” that could
be adopted by academic institutions and funding agencies.
It is worth noting that the development of guidelines in this
area is relatively recent. It dates back to the 1980s in the
US and the late 1990s in Europe, when a number of high-
profile cases of data fabrication and falsification by scien-
tists were uncovered and investigated by ad hoc commit-
tees. Although misconduct in science has always existed
[2], it is only in the past few decades that academic institu-
tions and the public opened their eyes to the sad reality that
scientists, like any human beings, may be tempted to en-
gage in fraudulent behaviour to achieve more rapidly their
personal or professional goals.
The new Code does not provide a proper definition of sci-
entific integrity, but delineates this concept indirectly by
presenting the basic principles that are relevant in this area:
(a) reliability in ensuring the quality of the research; (b)
honesty in developing the research work and in presenting
its results; (c) respect for persons, society and the environ-
ment; and (d) accountability for the research and its im-
pact. These principles are directly inspired by the European
Code of Conduct for Research Integrity developed in 2017
by the European federation of academies of sciences and
humanities (ALLEA).
After outlining the four basic principles, the Code makes
a number of general recommendations relating to their im-
plementation. These recommendations concern a great va-
riety of topics such as the need to promote a culture of in-
tegrity within academic institutions and funding agencies;
the importance that those who participate in collaboration
between institutions agree sufficiently in advance about the
format to be used for the publication and dissemination of
research results; the value of complying with the rules on
data management, such as the duty to store the data appro-
priately and for a certain period of time; the recommen-
dation that scientists should commit to making their work
available to a wide audience as soon as possible, in accor-
dance with the Open Science principle, unless it was other-
wise agreed; the importance of impartiality when selecting
reviewers for the evaluation of manuscripts, research pro-
posals and appointments; etc.
Two of the recommendations deserve special attention.
One concerns the teaching of scientific integrity; the other
relates to the concept of "authorship":
(a) Teaching of scientific integrity. The Code declares that
educational and research institutions should promote the
basic principles in their research and teaching activities.
After drawing attention to the value of “a strong culture of
scientific integrity (…) especially in connection with the
training and development of young scientists” (Section 2),
the Code points out that “scientific integrity is a fundamen-
tal part of education and training” (Section 4) and that in-
stitutions need to “incorporate the basic principles into the
teaching” and to “hold training courses” (ibid.). Certainly
no one can disagree with these general statements, but the
absence of more concrete recommendations in this crucial
area is regrettable. For instance, the Code could have urged
the inclusion of mandatory courses on research integrity
into the curriculum of master’s and doctoral programmes
in all disciplines. Or, as is suggested by the main German
guidelines on scientific integrity, the Code could have rec-
ommended that education in this area “begins at the earli-
est possible stage in academic teaching and research train-
ing” [3, Guideline 2] or that junior scientists should attend
“regular training sessions” on this subject [4, Guideline
3]. In the US, the National Academy of Sciences (NAS)
has assigned a central role to education in this area since
the early 1990s. Accordingly, it has proposed very con-
crete educational measures to ensure that early career re-
searchers acquire the knowledge, skills and attitudes they
need to do research in conformity with the rules for good
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goal is not just one element among others in the promotion
of scientific integrity, but it is “the most important one” be-
cause “ethical conduct is not likely to occur without effec-
tive education” [6].
(b) Authorship. In principle, the Code defines the notion of
‘authorship’ in similar terms as those used by most guide-
lines: an "author" is “someone who has made a signif-
icant personal contribution to the planning, implementa-
tion, quality, and where necessary, revision of a piece of
scientific research” (para. 4.4). For instance, according to
the widely used definition of authorship by the Interna-
tional Committee of Medical Journal Editors (ICMJE), an
"author" is someone who has made “substantial contribu-
tions to the conception or design of the work; or the ac-
quisition, analysis, or interpretation of data for the work”
[7]. The crucial question is of course what is meant by a
"significant" (or "substantial") contribution. Generally, this
notion is understood as meaning “an important intellec-
tual contribution, rather than technical assistance, without
which the work, or an important part of the work, could
not have been completed or the manuscript could not have
been written and submitted for publication” [8]. In contrast
to this understanding, the Code accepts that the "significant
contribution" can simply consist of an “act of insight” (in
German: “Akt des Erkennens”; in French: “acte de recon-
naissance”) that may result from the experience or knowl-
edge of a senior researcher. This very broad notion of au-
thorship, which was not included in the 2008 guidelines,
originates from a statement issued by the SAAS in 2013
[9]. It is true that, at least in theory, a feedback or advice
given by a senior researcher can significantly contribute to
improving the quality and originality of a manuscript, and
this may justify including him or her as a coauthor of the
paper. However, in practice, special caution will be needed
to prevent the vague notion of "act of insight" being used
to justify what in reality is a "gift (or honorary) author-
ship". This latter concept refers to the regrettable practice
of adding as coauthors researchers (for instance, the direc-
tor of the unit or the supervisor) who have not substantially
contributed to the research. Today it is widely established
that anyone who has given some support or advice in the
writing of a paper, but who does not meet the requirements
for authorship should be included in the Acknowledgments
section, and not listed as a coauthor.
Section 5 of the Code presents the different forms of scien-
tific misconduct. Compared with the 2008 guidelines, the
list of practices that are labelled as misconduct has been
expanded and presented in much more detail. Whereas the
previous guidelines were rather succinct in this regard and
simply distinguished between “infringements against sci-
entific interests” and “infringements against individual in-
terests”, the new Code abandons this somehow artificial
distinction and follows a better structure to categorise the
various forms of misconduct.
One shortcoming to highlight here is that almost no atten-
tion is paid to the need to protect whistleblowers (those
who report insider knowledge about misconduct within the
institution). Only one short sentence refers to the “discrim-
ination against persons who have reported scientific mis-
conduct” as a form of misconduct (para. 5.2.10). First,
a terminological remark: the term "discrimination" seems
inadequate to capture the notion of retaliatory measures
against whistleblowers. Interestingly, the German version
employs the term "Benachteiligung", which means a "dis-
advantage" and is more appropriate to convey the idea of
retaliation. But besides this terminological question, it is
unfortunate that the Code pays so little attention to an is-
sue that has become prominent in recent years in acade-
mic and research institutions, including in Switzerland. In
Germany, the Max-Planck-Society guidelines on good sci-
entific practice devote an entire section to whistleblower
protection [4, Section 9]. In 2015, the World Health Or-
ganization developed a very detailed policy document on
whistleblower protection, which could also inspire guide-
lines on scientific integrity [10]. It is true that the procedur-
al section of the Code indirectly refers to this topic when
it states that those who made allegations of misconduct
have “the right to confidentiality” and should be protected
“against possible discrimination or reprisals” (para. 6.4.5).
However, this is still too little. Whistleblower protection
is a sufficiently important topic to have deserved a more
prominent and visible place in the Code.
The last section of the Code describes in greater detail
than in the 2008 guidelines the procedures and rules for re-
viewing allegations of scientific misconduct. In general, it
is up to each institution (for instance, each university) to
establish review bodies on a case-by-case basis to inves-
tigate potential violations of scientific integrity that have
occurred within the institution. The Code also encourages
the creation of permanent committees to promote scientific
integrity by means of publications, training, conferences,
etc. These committees, however, are not supposed to be in-
volved in dealing with particular cases of misconduct.
In conclusion, the new Code is a step in the right direction.
The mere decision to update the 2008 guidelines sends a
good signal to the research community about the increas-
ing importance attached to scientific integrity. The Code
specifies the main ethical principles that are relevant in
this area and presents in greater detail than in the previous
guidelines the various forms of scientific misconduct and
the procedures to follow for addressing allegations of mis-
conduct. Nevertheless, it is unfortunate that many of the
recommendations are vaguely worded and lack concrete
suggestions for their implementation. In addition, key is-
sues (such as education in research integrity and whistle-
blower protection) are virtually ignored. In sum, the Code
is a valuable initiative but it is still not enough. Further and
more specific guidance in this area will be needed in the
coming years to promote effectively a culture of scientific
integrity.
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